BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16601830)

  • 1. Association of factor V gene polymorphisms (Leiden; Cambridge; Hong Kong and HR2 haplotype) with recurrent idiopathic pregnancy loss in Tunisia. A case-control study.
    Zammiti W; Mtiraoui N; Mercier E; Abboud N; Saidi S; Mahjoub T; Almawi WY; Gris JC
    Thromb Haemost; 2006 Apr; 95(4):612-7. PubMed ID: 16601830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary thrombophilia in Mexico IV: frequency of the Leiden, Cambridge, Hong Kong, Liverpool and HR2 haplotype polymorphisms in the factor V gene of a group of thrombophilic Mexican Mestizo patients.
    Ruiz-Argüelles GJ; Poblete-Naredo I; Reyes-Núñez V; Garcés-Eisele J; López-Martínez B; Gómez-Rangel JD
    Rev Invest Clin; 2004; 56(5):600-4. PubMed ID: 15776863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between adverse pregnancy outcomes and maternal factor V G1691A (Leiden) and prothrombin G20210A genotypes in women with a history of recurrent idiopathic miscarriages.
    Mahjoub T; Mtiraoui N; Tamim H; Hizem S; Finan RR; Nsiri B; Almawi WY
    Am J Hematol; 2005 Sep; 80(1):12-9. PubMed ID: 16138341
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factor V Leiden and G20210A prothrombin mutations in patients with recurrent pregnancy loss: data from the southeast of Turkey.
    Altintas A; Pasa S; Akdeniz N; Cil T; Yurt M; Ayyildiz O; Batun S; Isi H
    Ann Hematol; 2007 Oct; 86(10):727-31. PubMed ID: 17572893
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The HR2 haplotype of factor V: effects on factor V levels, normalized activated protein C sensitivity ratios and the risk of venous thrombosis.
    de Visser MC; Guasch JF; Kamphuisen PW; Vos HL; Rosendaal FR; Bertina RM
    Thromb Haemost; 2000 Apr; 83(4):577-82. PubMed ID: 10780320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case control study of deep venous thrombosis in relation to factor V G1691A (Leiden) and A4070G (HR2 Haplotype) polymorphisms.
    Bouaziz-Borgi L; Nguyen P; Hezard N; Musharrafieh U; Almawi WY; Mahjoub T
    Exp Mol Pathol; 2007 Dec; 83(3):480-3. PubMed ID: 17555744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of factor V G1691A (factor V-Leiden) and prothrombin G20210A gene mutations in a recurrent miscarriage population.
    Finan RR; Tamim H; Ameen G; Sharida HE; Rashid M; Almawi WY
    Am J Hematol; 2002 Dec; 71(4):300-5. PubMed ID: 12447960
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrent abortions in Asian Indians: no role of factor V Leiden Hong Kong/Cambridge mutation and MTHFR polymorphism.
    Biswas A; Choudhry P; Mittal A; Meena A; Ranjan R; Choudhry VP; Saxena R
    Clin Appl Thromb Hemost; 2008 Jan; 14(1):102-4. PubMed ID: 18160599
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Factor V HR2 haplotype: a risk factor for venous thromboembolism in individuals with absence of Factor V Leiden.
    Otrock ZK; Taher AT; Shamseddeen WA; Zaatari G; Bazarbachi A; Mahfouz RA
    Ann Hematol; 2008 Dec; 87(12):1013-6. PubMed ID: 18654780
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polymorphisms in factor V and antithrombin III gene in recurrent pregnancy loss: a case-control study in Indian population.
    Sharma A; Bhakuni T; Ranjan R; Kumar R; Kishor K; Kamal VK; Mahapatra M; Jairajpuri MA; Saxena R
    J Thromb Thrombolysis; 2015 May; 39(4):481-8. PubMed ID: 25771983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of antiphospholipid antibodies, factor V G1691A (Leiden) and prothrombin G20210A mutations in early and late recurrent pregnancy loss.
    Mtiraoui N; Borgi L; Hizem S; Nsiri B; Finan RR; Gris JC; Almawi WY; Mahjoub T
    Eur J Obstet Gynecol Reprod Biol; 2005 Apr; 119(2):164-70. PubMed ID: 15808373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of endothelial protein C receptor haplotypes, factor V Leiden and recurrent first trimester pregnancy loss.
    Hopmeier P; Puehringer H; van Trotsenburg M; Atamaniuk J; Oberkanins C; Dossenbach-Glaninger A
    Clin Biochem; 2008 Aug; 41(12):1022-4. PubMed ID: 18539144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular analysis of factor V Leiden, factor V Hong Kong, factor II G20210A, methylenetetrahydrofolate reductase C677T, and A1298C mutations related to Turkish thrombosis patients.
    Dölek B; Eraslan S; Eroğlu S; Kesim BE; Ulutin T; Yalçiner A; Laleli YR; Gözükirmizi N
    Clin Appl Thromb Hemost; 2007 Oct; 13(4):435-8. PubMed ID: 17911197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FV HR2 haplotype as additional inherited risk factor for deep vein thrombosis in individuals with a high-risk profile.
    Margaglione M; Bossone A; Coalizzo D; D'Andrea G; Brancaccio V; Ciampa A; Grandone E; Di MG
    Thromb Haemost; 2002 Jan; 87(1):32-6. PubMed ID: 11848454
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factor V Leiden mutation: a treatable etiology for sporadic and recurrent pregnancy loss.
    Glueck CJ; Gogenini S; Munjal J; Tracy T; Pranikoff J; Wang P
    Fertil Steril; 2008 Feb; 89(2):410-6. PubMed ID: 17582408
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between factor V Leiden mutation and poor pregnancy outcomes among Palestinian women.
    Hussein AS; Darwish H; Shelbayeh K
    Thromb Res; 2010 Aug; 126(2):e78-82. PubMed ID: 20605623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombophilias and recurrent pregnancy loss.
    Kutteh WH; Triplett DA
    Semin Reprod Med; 2006 Feb; 24(1):54-66. PubMed ID: 16418978
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coagulation factor V G allele and HR2 haplotype: factor V activity, activated protein C resistance and risk of venous thrombosis.
    Kostka H; Schwarz T; Schellong S; Mix C; Kuhlisch E; Temelkova-Kurktschiev T; Henkel E; Köhler C; Gehrisch S; Siegert G
    Blood Coagul Fibrinolysis; 2003 Jan; 14(1):49-56. PubMed ID: 12544728
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Genetic thrombophilic defects (Factor V Leiden, prothrombin G20210A, MTHFR C677T) in women with recurrent fetal loss].
    Kovacheva K; Ivanov P; Konova E; Simeonova M; Komsa-Penkova R
    Akush Ginekol (Sofiia); 2007; 46(7):10-6. PubMed ID: 18333414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multiple thrombophilic gene mutations rather than specific gene mutations are risk factors for recurrent miscarriage.
    Coulam CB; Jeyendran RS; Fishel LA; Roussev R
    Am J Reprod Immunol; 2006 May; 55(5):360-8. PubMed ID: 16635210
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.